# Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

> **NCT00127595** · PHASE2 · TERMINATED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 28 (—)

## Conditions studied

- Carcinoma, Transitional Cell

## Interventions

- **DRUG:** gemcitabine, oxaliplatin

## Key facts

- **NCT ID:** NCT00127595
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 28 (—)
- **Last updated:** 2005-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127595, "Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00127595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*